Sign in

Icro Meattini

@icromeattini.bsky.social
250 followers 139 following 12 posts

Professor, Florence University, Italy. Radiation/Clinical Oncologist. Head, Breast Unit at Florence Univ Hospital. Father. Opinions are my own. RT not endorse.

PostsRepliesMedia
Reposted by Icro Meattini
The OncoAlert Network 🚨 @oncoalert.bsky.social · 03/02/2026
The #OncoAlertColloquium 2026 Breast Malignancies🚨 DAY TWO Presentation by Dr. Icro Meattini🇮🇹 Year in Review in #BreastCancer Radiation Therapy REGISTER HERE TO WATCH: buff.ly/OhocR7D In this presentation, Dr. Meattini highlights key practice-changing evidence from 2025 shaping modern breast RT ☢️
011
Reposted by Icro Meattini
The OncoAlert Network 🚨 @oncoalert.bsky.social · 03/02/2026
DAY TWO of the Colloquium Covering #BreastCancer Now Available On Demand!! Watch Here👉 vimeo.com/event/5689351 However it requires a password, to receive the password Register here👉 oncoalert.m-pages.com/7I0mwF/the-2... Year in Review in #BreastCancer brought to you by an amazing faculty
011
Reposted by Icro Meattini
European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 13/11/2025
🌟 #ESTRO26 hits a new record! 🌟 4,091 abstracts submitted — over 500 more than last year! 🚀 Thank you to our incredible community! 💛Your research is what makes ESTRO the truly international hub of innovation in #radiotherapy. #ScientificExcellence #InnovationInCancerCare
031
Reposted by Icro Meattini
The OncoAlert Network 🚨 @oncoalert.bsky.social · 06/10/2025
Ping @maryamlustberg.bsky.social @drsgraff.bsky.social @stage4kelly.bsky.social @itsnotpink.bsky.social @coffeemommy.bsky.social @icromeattini.bsky.social @realbowtiedoc.bsky.social @barbaramelao.bsky.social @drnataliagandur.bsky.social
021
Reposted by Icro Meattini
Sonja Dieterich @sonjadieterich.bsky.social · 26/09/2025
See you all at #ASTRO25! #MedPhys #radoncsky
031
Reposted by Icro Meattini
IMPORTANT EU Project @importanteuproject.bsky.social · 03/09/2025
🎥 New video out! Excited to share the story of the IMPORTANT Project-the mission, clinical goals & innovative approach to optimizing CDK4/6-inhibitor treatment for older patients with advanced breast cancer ▶️ Watch the video: play.mediaflow.com/ovp/17/72DFN... 🔗 Learn more: important-project.com
041
Reposted by Icro Meattini
Elisabetta Bonzano MD, PhD @elisabettabonzano.bsky.social · 03/06/2025
📌 Opting Out of Therapy for Early-Stage Breast Cancer: How Far Might We Go? ✨Prof @icromeattini.bsky.social 👉🏻 How to Integrate Radiotherapy Into Current Treatment Concepts❗️ @oncoalert.bsky.social #OncoAlertAF #ASCO25 #RadOnc
053
Reposted by Icro Meattini
Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 31/05/2025
Coming up today: Medical oncology/hematology fellow Dr. Emma Schatoff's poster session on "Risk factors associated with de novo metastatic colorectal cancer in early onset colorectal cancer" TODAY at the 2025 @ascocancer.bsky.social Annual Meeting. #ASCO25. 🗓️: 5/31 from 9-12pm CT
063
Reposted by Icro Meattini
American Society of Clinical Oncology @ascocancer.bsky.social · 31/05/2025
@cliffordhudis.bsky.social at #ASCO25: ~40% cut to NCI budget in Admin's '26 proposal. We are in a tragic paradox: remarkable science & historic cuts to resources needed to turn these opps into hope for millions of pts. Our advocacy, is more important than ever ➡️ brnw.ch/21wT3U4
brnw.ch
Federal Funding for Cancer Research
As Congress negotiates Fiscal Year 2025 appropriations bills, urge them to make cancer research a top priority.
02514
Reposted by Icro Meattini
The OncoAlert Network 🚨 @oncoalert.bsky.social · 22/05/2025
The OncoAlert🚨ROUND UP Now Out‼️ Covering May 15-22, 2025 REGISTER at oncoalert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa... youtu.be/xgIw0BISCpo @elisaagostinetto.bsky.social @barbaramelao.bsky.social @elisaagostinetto.bsky.social @icromeattini.bsky.social @realbowtiedoc.bsky.social
youtu.be
The OncoAlert Oncology Round Up May 15-22, 2025 Top Oncology Breakthroughs in less than 5 Min!
YouTube video by OncoAlert 360
084
Reposted by Icro Meattini
The OncoAlert Network 🚨 @oncoalert.bsky.social · 22/05/2025
The VJ OA Oncology Journal Club Dr. Evandro de Azambuja discussing APHINITY in #BreastCancer now on APPLE PODCASTS podcasts.apple.com/se/podcast/o... @elisaagostinetto.bsky.social @elisabettabonzano.bsky.social @icromeattini.bsky.social @maryamlustberg.bsky.social
podcasts.apple.com
VJ OA Oncology Journal Club: Final Results of the APHINITY Breast Cancer Trial Presented at ESMO Breast 2025
Poddavsnitt · OncoAlert · 2025-05-16 · 3 min
032
Reposted by Icro Meattini
Wendy Woodward, MD, PhD @ibcradiation.bsky.social · 10/05/2025
Hola #medsky #cansky #radonc #bcsm NRG Oncology is here👇🏻👇🏻 Give them a follow!
083
Reposted by Icro Meattini
OncoDaily @oncodaily.bsky.social · 02/05/2025
Kicking Off ESTRO25: What’s Happening on Day 1 @estroradiotherapy.bsky.social @cancerphysicist.bsky.social @icromeattini.bsky.social @gerryhanna.bsky.social oncodaily.com/blog/estro25... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESTRO25 #ESTRO2025
oncodaily.com
Kicking Off ESTRO25: What’s Happening on Day 1 - OncoDaily
Kicking Off ESTRO25: What’s Happening on Day 1 / Aileen Duffton, Alizée Camps, Anamaria Girbovan, Ananya Choudhury, Ane Appelt, Beatson, Ben Heijmen,
092
Reposted by Icro Meattini
European Organisation for Research and Treatment of Cancer @eortc.org · 02/05/2025
✨We're thrilled to be taking part in #ESTRO25 in Vienna! EORTC researchers will be presenting cutting-edge findings in #RadiationOncology, a cornerstone of our scientific strategy. Find out more: www.eortc.org/blog/2025/05... @estroradiotherapy.bsky.social #CancerResearch
074
Reposted by Icro Meattini
Ane Appelt @cancerphysicist.bsky.social · 02/05/2025
ESTRO25 has kicked off! And what a start - absolutely amazing keynote talk by Pascal Uffer, providing a combined patient and entrepreneur perspective on optimising cancer treatment #ESTRO25 #RadOnc
161
Reposted by Icro Meattini
Ahmed Gawish @gawish.bsky.social · 02/05/2025
What a start , @mguckenberger.bsky.social with an emotional and inspiring talk at the opening Ceremony, Pascal Uffer delivered more than a talk ; if cancer were a start up. #ESTRO25 #radonc #radiotherapy
091
Reposted by Icro Meattini
Elizabeth Forde @elizabethforde.bsky.social · 08/04/2025
Thinking about your next move in #RadiationTherapy? Join us on May 15th for a free online info session and explore how our flexible, fully online postgrad programmes can help you specialise, lead, or innovate to reach your clinical and research goals. 📆 Register here: bit.ly/RadTherapy2025
bit.ly
Postgraduate MSc/Cert/Dip in Advanced Radiotherapy Practice - Open Evening
A fully online seminar to learn more about the Masters/Postgraduate Diploma/Certificate MSc in Advanced Radiotherapy Practice.
061
Reposted by Icro Meattini
Icro Meattini @icromeattini.bsky.social · 27/02/2025
Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential IMRT and VMAT for Whole Breast Irradiation #BreastCancer #medphys #radonc #OncoAlert @oncoalert.bsky.social Free 50-day link: www.advancesradonc.org/article/S245...
advancesradonc.org
Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Whole Breast Irradiation
This study evaluates the use of the mCycle automated planning system integrated into the Monaco Treatment Planning System for step-and-shoot intensity modulated radiation therapy (IMRT) and volumetric...
054
Icro Meattini @icromeattini.bsky.social · 27/02/2025
Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential IMRT and VMAT for Whole Breast Irradiation #BreastCancer #medphys #radonc #OncoAlert @oncoalert.bsky.social Free 50-day link: www.advancesradonc.org/article/S245...
advancesradonc.org
Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Whole Breast Irradiation
This study evaluates the use of the mCycle automated planning system integrated into the Monaco Treatment Planning System for step-and-shoot intensity modulated radiation therapy (IMRT) and volumetric...
054
Icro Meattini @icromeattini.bsky.social · 09/02/2025
Long-Term Outcomes of #Radiation Monotherapy Versus Combined RT + Hormone Therapy in Low-Risk Early-Stage #BreastCancer Patients 70 Years or Older After Breast-Conserving Surgery @oncoalert.bsky.social #OncoAlert @ijrobp.bsky.social #radonc www.redjournal.org/article/S036...
redjournal.org
Long-Term Outcomes of Radiation Monotherapy Versus Combined Radiation Monotherapy + Hormone Therapy in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older After Breast-Conserving Surgery
Standard therapy for breast cancer after breast-conserving surgery is radiation therapy (RT) plus hormone therapy (HT). For patients with a low-risk of recurrence, there is an interest in deescalating...
075
Reposted by Icro Meattini
Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 07/02/2025
📢 Just published! A phase II study of #abemaciclib for patients with #retinoblastoma-positive, triple-negative #metastatic breast cancer. 🔓https://pubmed.ncbi.nlm.nih.gov/39908010/ @drtimothyerick.bsky.social @nlinmd.bsky.social @stolaney1.bsky.social
074
Reposted by Icro Meattini
Wendy Woodward, MD, PhD @ibcradiation.bsky.social · 05/02/2025
#radonc #medsky #cansky
031
Reposted by Icro Meattini
UC San Diego Rad Med @ucsdradmed.bsky.social · 05/02/2025
UC San Diego Rad Med is now on BlueSky! We are excited to connect and engage with the #radonc and #medphys community!
0102
Reposted by Icro Meattini
Elisabetta Bonzano MD, PhD @elisabettabonzano.bsky.social · 06/02/2025
Day Three #OncoAlertColloquium 🚨 #BreastCancer REGISTER for FREE HERE👉 buff.ly/4gsEa2f prof @icromeattini.bsky.social 🇮🇹 👏🏻 Radiation Oncology in Breast Cancer: Year in Review @oncoalert.bsky.social
042
Reposted by Icro Meattini
Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 06/02/2025
Congrats to all the new Fellows of @ascocancer.bsky.social especially Drs Arjun Gupta, @ryannipp.bsky.social, and @lymphomadoc.bsky.social 🙌🙌🙌 Excited to be in your FASCO class and celebrate with you in Chicago this year. 🥳
ASCO
CONGRATULATIONS
FASCO™ RECIPIENTS
Jeanny B. Aragon-Ching, MD, FACP, FASCO
Himisha Beltran, MD, FASCO
Kathleen E. Bickel, MD, FACP,
MPhil, FASCO
Sam Brondfield, MD, MA, FASCO Shirish M. Gadgeel, MD, FASCO Sanjay Goel, MD, MS, FASCO
Michael S. Gordon, MD, FASCO
Stacy W. Gray, MD, FASCO Arjun Gupta, MD, FASCO
Richard M. Ingram, MD, FASCO Claudine Isaacs, MD, FRCPC, FASCO
Inga T. Lennes, MD, MPH, MBA, FASCO
Heather L. McArthur, MD, MPH, FASCO
Ryan D. Nipp, MD, FASCO
Amy C. Peterson, MD, FASCO
Lesley K. Seymour, MD, PhD,
FASCO
Sara M. Tolaney, MD, MPH, FASCO
Anne S. Tsao, MD, FASCO
Jason Westin, MD, MS, FACP, FASCO
0143
Reposted by Icro Meattini
The OncoAlert Network 🚨 @oncoalert.bsky.social · 05/02/2025
Day3⃣ #OncoAlertColloquium 🚨 #BreastCancer REGISTER for FREE HERE👉 buff.ly/3Q6ttHY @Icro_Meattini 🇮🇹 Radiation Oncology in Breast Cancer: Year in Review REGISTER NOW for a Live chat with Dr. Meattini @icromeattini.bsky.social @elisaagostinetto.bsky.social @elisabettabonzano.bsky.social
011
Icro Meattini @icromeattini.bsky.social · 04/02/2025
United in our goals - equity of access for all our patients #WorldCancerDay #radonc #medonc #breastcancer #OncoAlert @oncoalert.bsky.social
071
Reposted by Icro Meattini
Europa Donna Albania @europadonnaal.bsky.social · 04/02/2025
Sot është Dita Botërore e Kancerit #WorldCancerDay ditë që na bashkon në luftën për një të ardhme më të mirë për pacientët me kancer në Shqipëri dhe kudo në botë🧡 Kjo nuk është vetëm një betejë për trajtim – është një betejë për dinjitet, për jetë dhe për një të ardhme më të drejtë për të gjithë!
172
Reposted by Icro Meattini
OncoDaily @oncodaily.bsky.social · 03/02/2025
CNS metastases are the main challenge in HER2+ breast cancer - Nelson Moss @mskcancercenter.bsky.social oncodaily.com/blog/nelson-... #BreastCancer #Cancer #MemorialSloanKettering #Health #OncoDaily #Oncology #Medicine
oncodaily.com
Nelson Moss: CNS metastases are the main challenge in HER2+ breast cancer - OncoDaily
Nelson Moss: CNS metastases are the main challenge in HER2+ breast cancer / Anne S. Reiner, Breast Cancer, cancer, Emanuela Ferraro, Nelson Moss, Neurosurgery
0123
Reposted by Icro Meattini
VJOncology @vjoncology.bsky.social · 04/02/2025
🌍 This #WorldCancerDay, we celebrate progress and innovation in the fight against cancer. Discover the groundbreaking advancements shaping oncology in 2024, from immunotherapy to personalised medicine. 💡🔬 Read more: buff.ly/3Ewkmha #Oncology #CancerResearch
buff.ly
2024 Clinical breakthroughs in Oncology - VJOncology
As 2024 comes to a close, it is essential to recognize the remarkable progress and ground-breaking achievements that have redefined...
031
Reposted by Icro Meattini
OncoDaily @oncodaily.bsky.social · 03/02/2025
Fixed dose of capecitabine vs standard dose for Metastatic Breast Cancer - Paolo Tarantino @ptarantinomd.bsky.social oncodaily.com/blog/236887 #BreastCancer #Cancer #MetastaticBreastCancer #Health #OncoDaily #Oncology #Medicine
oncodaily.com
Paolo Tarantino: Fixed dose of capecitabine vs standard dose for Metastatic Breast Cancer - OncoDaily
Paolo Tarantino: Fixed dose of capecitabine vs standard dose for Metastatic Breast Cancer / Breast Cancer, cancer, Colleen Bohnenkamp, Holly E. Smith, JCO,
0121
Reposted by Icro Meattini
OncoDaily @oncodaily.bsky.social · 03/02/2025
The results of our translational research project on lobular breast cancer at BSMO25 - Elisa Agostinetto @elisaagostinetto.bsky.social oncodaily.com/blog/elisa-a... #BreastCancer #BSMO25 #Cancer #OncoDaily #Oncology #Medicine #Health
oncodaily.com
Elisa Agostinetto: The results of our translational research project on lobular breast cancer at BSMO25 - OncoDaily
Elisa Agostinetto: The results of our translational research project on lobular breast cancer at BSMO25 / Breast Cancer, BSMO25, cancer, Elisa Agostinetto,
0112
Reposted by Icro Meattini
Mechthild Krause, Prof. @mekrause.bsky.social · 30/01/2025
Higher NTCP with variable RBE predictions in Proton RT of brain tumours- especially for blindness and deppendent in Patient factors. LET or track-end optimization can lower the risk. @hzdr.bsky.social @oncoalert.bsky.social www.sciencedirect.com/science/arti...
sciencedirect.com
Variable-RBE-induced NTCP predictions for various side-effects following proton therapy for brain tumors – Identification of high-risk patients and risk mitigation
Disregarding the increase of relative biological effectiveness (RBE) may raise the risk of acute and late adverse events after proton beam therapy (PB…
054
Reposted by Icro Meattini
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 30/01/2025
*NEW* Review from Prof Rob Bristow's lab on the relationship between #hypoxia in tumours, genomic instability and tumour #evolution "Possible ways to counter the effects of hypoxia to block tumour evolution and improve treatment outcomes are described." @mcrcnews.bsky.social @cancerresearchuk.org
074
Reposted by Icro Meattini
Icro Meattini @icromeattini.bsky.social · 18/01/2025
Biomarker-Directed Radiotherapy in Breast Cancer: A Narrative Review is out JAMA oncol! @jama.com A robust clinical and analytical validation of biomarkers to ensure clinical utility for RT optimization is still needed ☢️ #radonc #OncoAlert @oncoalert.bsky.social jamanetwork.com/journals/jam...
jamanetwork.com
Biomarker-Directed Radiotherapy in Breast Cancer
This narrative review explores the potential of biomarker-directed personalized radiotherapy approaches.
132
Reposted by Icro Meattini
The OncoAlert Network 🚨 @oncoalert.bsky.social · 29/01/2025
The OncoAlert Colloquium🚨NEXT WEEK FREE REGISTRATION HERE👉 buff.ly/3CChgre @drchoueiri.bsky.social @icromeattini.bsky.social @yukselurun.bsky.social @aftimosp.bsky.social @jrgralow.bsky.social @elisabettabonzano.bsky.social @elisaagostinetto.bsky.social @lymphomadoc.bsky.social
143
Reposted by Icro Meattini
The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · 17/01/2025
Cancer Statistics Just Out for 2025 out on American Cancer Society Journals acsjournals.onlinelibrary.wiley.com/doi/epdf/10.... #ProstateCancer has one of the highest contemporary survival rates at 97%, followed closely by testicular cancer (95%) and melanoma (94%)
084
Icro Meattini @icromeattini.bsky.social · 18/01/2025
Biomarker-Directed Radiotherapy in Breast Cancer: A Narrative Review is out JAMA oncol! @jama.com A robust clinical and analytical validation of biomarkers to ensure clinical utility for RT optimization is still needed ☢️ #radonc #OncoAlert @oncoalert.bsky.social jamanetwork.com/journals/jam...
jamanetwork.com
Biomarker-Directed Radiotherapy in Breast Cancer
This narrative review explores the potential of biomarker-directed personalized radiotherapy approaches.
132
Reposted by Icro Meattini
Elizabeth Forde @elizabethforde.bsky.social · 03/12/2024
Who knew 2hours could go so quickly! Great discussions from a global perspective tackling topics influencing recruitment and retention of Radiation Therapists #ProtectOurWorkforce #ESTRO #RTT Workshop
092
Reposted by Icro Meattini
IJROBP @ijrobp.bsky.social · 29/11/2024
Nov 30 is the final deadline for the Adaptive special issue. Enjoying the spirit of creativity and innovation in #radonc! Exclusive tip just for #radoncsky - the next CFP by @drdavidpalma.bsky.social tentatively being focused on clinical trials in SBRT and next maybe particles. Comments welcomed.
1104
Reposted by Icro Meattini
Kristina Jankovic @kjankovic.bsky.social · 10/01/2025
Dear colleagues, Join us for the 5th #OncoAlert Colloquium! 🚨🌟 👉 buff.ly/3CChgre 👈 📅 February 3-9, 2025 🎟️ FREE Registration 📰one week covering the latest in oncology Don’t miss this unique #oncology event! 🌍👩‍⚕️👨‍⚕️ @oncoalert.bsky.social #OncoAlertAF
buff.ly
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
051
Reposted by Icro Meattini
Jeffrey Peppercorn MD @ethicsdoctorp.bsky.social · 11/01/2025
Out today! 🤩 JCO Oncology Practice Special Issue dedicated to the challenge of Financial Toxicity in Oncology. Great work by @fumikochino.bsky.social @ryannipp.bsky.social pulling this issue together.
0146
Reposted by Icro Meattini
Simulated Annealing @handle.invalid · 10/01/2025
‼️ EUROPA Stage I HR+ breast cancer in women 70+ -> lumpectomy -> APBI vs endocrine Better QoL with APBI! Very important trial! #radonc @icromeattini.bsky.social
021
Reposted by Icro Meattini
The OncoAlert Network 🚨 @oncoalert.bsky.social · 03/01/2025
Clinical Case Challenges on Castrate Resistant Prostate Cancer by Mirrors of Medicine (Free & CME Accredited) Link to access👉 buff.ly/4ipSU4o Join the Mirrors of Medicine PinPoint Case Platform, a case-based CME tool that helps apply the latest evidence to practice.
041
Reposted by Icro Meattini
NEJM.org @nejm.org · 03/01/2025
Accounting for approximately 350,000 deaths annually worldwide, cervical cancer is preventable with HPV vaccination and screening. Newer chemotherapy, radiotherapy, and immunotherapy techniques have improved survival. Learn more in a new review: nej.md/41Rw0gb #MedSky #oncology
Image showing worldwide age-standardized incidence and mortality rates for cervical cancer in 2022. Data are from the GLOBOCAN database and were collated by the International Agency for Research on Cancer and hosted by the Global Cancer Observatory.
13812
Reposted by Icro Meattini
Elisa Agostinetto @elisaagostinetto.bsky.social · 03/01/2025
What is the impact of drug-drug interactions between palbociclib and proton pump inhibitors in #breastcancer? 💊 Can PPI use explain why the PALLAS trial was negative? Now out in @ESMO_Open our analysis of #PALLAS exploring this question👇🏻 @oncoalert.bsky.social www.sciencedirect.com/science/arti...
sciencedirect.com
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
Concomitant intake of proton pump inhibitors (PPIs) may create drug–drug interactions, potentially impacting efficacy of anticancer agents. In the pha…
0157
Reposted by Icro Meattini
VJOncology @vjoncology.bsky.social · 29/12/2024
🎥 @icromeattini.bsky.social‬ highlights post-surgery breast cancer treatment de-escalation strategies like partial breast irradiation & hypofractionation, reducing treatment burden: ➡️ buff.ly/4gQPsxT ⬅️ @sabcs.bsky.social #SABCS24 #BreastCancer
buff.ly
De-escalating treatment in patients with breast cancer post-surgery - VJOncology
Icro Meattini, MD, University of Florence, Florence, Italy, comments on the current treatment strategies for patients after breast cancer surgery,...
041
Reposted by Icro Meattini
The OncoAlert Network 🚨 @oncoalert.bsky.social · 14/12/2024
Shout out to our faculty @drsgraff.bsky.social @erikahamilton9.bsky.social @hoperugo.bsky.social @elisaagostinetto.bsky.social @elisabettabonzano.bsky.social @icromeattini.bsky.social @tmprowell.bsky.social (Honorary Faculty) @stolaney1.bsky.social @fernandoonco.bsky.social
041
Reposted by Icro Meattini
Julie Gralow @jrgralow.bsky.social · 21/12/2024
Artifical Intelligence research presented at the @ascocancer.bsky.social 2024 annual meeting. dailynews.ascopubs.org/do/ai-empowe...
dailynews.ascopubs.org
The AI-Empowered Oncologist: A Look Back at ASCO24 Research to Improve Clinical Use
The use of artificial intelligence (AI) was a central theme at the 2024 ASCO Annual Meeting, including many tools, such as large language models, clinical trial matching, and image assessment, that ar...
072
Reposted by Icro Meattini
Elisabetta Bonzano MD, PhD @elisabettabonzano.bsky.social · 27/12/2024
The @oncoalert.bsky.social Newsletter NOW OUT‼️ Covering December 20-26, 2024🎄 👉🏻REGISTER AT www.OncoAlert360.com OR buff.ly/48Xpgz0 📩📩📩
041